What’s in the “Costs and Incomes” report for 2024?
Article L. 111-11 of the French Social Security Code stipulates that each year, before June 15, the National Union of…
Health products pricing : clarification of the “industrial criterion”
In a context of increasing supply tensions and stock-outs, the Social Security Financing Act ("LFSS") for 2022 added an "industrial…
PLFSS: medical devices soon to be substitutable by pharmacists
Article 31 bis of the Social Security Financing Bill (PLFSS) for 2023 provides for the possibility for pharmacists to substitute…
PLFSS: Creation of a specific financing method for advanced therapy medicinal products
The Social Security Financing Bill (PLFSS) for 2023, adopted today in first reading by the Senate, proposes to set up…
PLFSS: New rebates for manufacturers who apply for reimbursement in a limited number of indications
The examination of the Social Security Financing Bill (PLFSS) for 2023 by the deputies began today. Articles 30 (for medicinal…
Biosimilars: the Council of State clarifies the notion of prescription efficiency
Let us recall that an experimental incentive mechanism was introduced on the basis of Article 51 of the Social Security…